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The merits and limits of pooling data from nuclear power 
w orker studies
Nuclear power plant workers are exposed to various 
sources of occupational radiation and are a suitable 
population to investigate the eﬀ ects of low and 
protracted exposure. Thus, since the 1970s, analyses 
have been done of data from a single power plant 
from one country, several plants from one country, 
and several plants from several countries. However, 
comparisons between results are hampered by diﬀ erent 
designs and diﬀ erent inclusion criteria. Risk estimates 
very between studies and larger studies or pooled 
analyses are needed to increase precision.
International pooling started in 1995, with a study 
that included data from Canada, the UK, and the USA.1 
Data were later added from a further 12 countries.2 In 
The Lancet Haematology, Klervi Leuraud and colleagues 
present results of extended follow-up for the INWORKS 
study,3 including cohorts from France,4 the UK,5 and 
the USA,6 and by contrast with the previous pooled 
analysis,2 included individuals exposed (or likely to have 
been exposed) to internally deposited radionuclides or 
to neutrons were included, which tripled the person-
years available and increased the number of deaths 
despite a reduced number of workers included. 
The results show an increased risk for leukaemia, with 
an excess relative risk of 2·32–3·68 per Gy depending 
on the latency period, whether socioeconomic status 
and internal deposition were adjusted for, whether the 
analysis was restricted to diﬀ erent dose ranges, and 
whether all or only two countries were included in the 
analysis. Most of these excess risks were statistically 
signiﬁ cant, but they were based on 90% CIs. In total 
about 70 CIs were presented in the paper. With this 
high number of statistical tests the chance of ﬁ nding 
statistically signiﬁ cant results is high, so the danger of 
false positives is not negligible and should be taken into 
consideration when interpreting the results.
The study provides supportive evidence on the 
radiation risks of leukaemia after exposure to low 
doses, using a large dataset and adequate statistical 
analysis. But limitations of this type of cohort study 
of nuclear workers have been discussed by Leuraud 
and colleagues and other investigators before,8 and 
they somewhat hamper the study’s conclusions. 
Heterogeneity between countries is present but not 
well understood, and its assessment can be a major 
challenge for a pooled analysis. The contribution of 
errors in the outcome variable (death certiﬁ cates 
from diﬀ erent countries covering more than 
50 years are included) is not known. Confounding 
by socioeconomic status and other lifestyle factors 
cannot be assessed completely. Additional risk factors, 
such as exposure to benzene and medical exposure to 
ionising radiation are not taken into account. Internal 
exposure to radionuclides, uranium, and plutonium 
are neither qualitatively nor quantitatively evaluated. 
Background radiation exposure might be larger than 
occupational exposure and was not incorporated into 
the analysis.
In my view, to properly understand the mechanisms 
and eﬀ ects of low-dose radiation, we need new data 
collected by comparable methods for all participants: 
excellent dosimetry for internal and external exposure, 
including organ doses, data for exposure to ionising 
radiation from other sources such as medical 
and background exposure, data on other known 
occupational risk factors, lifestyle factors, biological 
material, genetic markers, and medical history, 
including information on screening and medical care. 
We need longitudinal (prospective) data (as we have 
from atomic-bomb survivors in Japan) to help us 
understand the dose–response relationship, interaction 
and confounding, and outcome pathways.9 We also 
need more sophisticated statistical analyses: not only 
for dose measurement errors,10 but also to deal with 
confounding, with errors in the outcome variable, with 
heterogeneity, multiple testing, and to model the dose–
response relationship.
Workers and the public can be protected from radiation 
by controlling the dose to prevent adverse health eﬀ ects, 
mainly cancer; however, a better understanding of the 
eﬀ ect of low-dose radiation is warranted. Large studies 
like INWORKS support current risk estimates, but new, 
creative prospective studies that include biological 
material and collaboration between radiation biologists 
and radiation epidemiologist are needed to clarify how 
low-dose radiation aﬀ ects human beings.
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